肾素 (Renin) 是一种单特异性酶,可催化血管紧张素 II 合成中的限速步骤。当肾素和肾素原与(肾素原)受体结合时,会发生增强的酶活性和其他生理效应。肾素表达和分泌的经典位点是肾小球旁细胞,其表达受生理线索的严格调控。
肾素原和与(肾素原)受体结合的肾素不仅会增加血管紧张素原向血管紧张素 I (Ang I) 的催化转化,而且还会上调促纤维化基因的表达。肾素在调节血压、电解质稳态、哺乳动物肾脏发育和纤维化/肥大性疾病进展方面起着关键作用。肾素抑制剂是治疗高血压的血管紧张素转换酶抑制剂 (ACEI) 的替代品。
Renin is a monospecific enzyme that catalyzes the rate-limiting step in the synthesis of angiotensin II. Amplified enzymatic activity and additional physiological effects occur when renin and pro-renin bind to the (pro)renin receptor. The classical site of renin expression and secretion is the renal juxtaglomerular cell, where its expression is tightly regulated by physiological cues.
Prorenin and renin bound to the (pro)renin receptor not only increase the catalytic conversion of angiotensinogen to angiotensin I (Ang I), but also upregulate the expression of profibrotic genes. Renin plays a critical role in the regulation of blood pressure, electrolyte homeostasis, mammalian renal development, and progression of fibrotic/hypertrophic diseases. Renin inhibitors represent an alternative to angiotensin-converting enzyme inhibitors (ACEI) for the treatment of hypertension.
Handle region peptide, rat 是一种肾素原 (prorenin) 受体拮抗剂,既能抑制糖尿病性肾病的进程,又对眼部炎症具有抵抗作用。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号